Trade war’s impact on medical technology industry a focus at MedTech Conference
The ongoing trade war between the United States and China, one of 2018’s biggest economic storylines, has continued to be a hot topic among healthcare providers and vendors.
Scott Whitaker, CEO of the Advanced Medical Technology Association (AdvaMed), discussed the months-long dispute on Sept. 24 at the annual MedTech Conference in Philadelphia.
“If the trade war continues and escalating continues to grow, there will be more impact,” Whitaker said, as quoted by Forbes writer Bruce Japsen.
During a presentation to member companies, the association emphasized that these tariffs involve both Chinese and U.S. products. They are estimated to impact $4.7 billion in U.S. medical technology exports alone.
AdvaMed advocates for policies throughout the world seeking to provide patients with timely access to high-quality care. The association has been vocal in recent months about its desire for the medical device tax to be permanently repealed.
Click below to read the full story from Forbes.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.